Cargando…
Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
BACKGROUND: Targeting ribosome biogenesis to activate p53 has recently emerged as a therapeutic strategy in human cancer. Among various ribosomal proteins, RPL11 centralizes the nucleolar stress-sensing pathway by binding MDM2, leading to MDM2 inactivation and p53 activation. Therefore, the identifi...
Autores principales: | Wang, Bingwu, Gao, Jian, Zhao, Zhongjun, Zhong, Xuefei, Cui, Hao, Hou, Hui, Zhang, Yanping, Zheng, Junnian, Di, Jiehui, Liu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450376/ https://www.ncbi.nlm.nih.gov/pubmed/36071402 http://dx.doi.org/10.1186/s10020-022-00537-x |
Ejemplares similares
-
Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation
por: Zheng, Jiangge, et al.
Publicado: (2015) -
Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012) -
Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway
por: Franklin, Derek A., et al.
Publicado: (2022) -
Genomic gain of RRS1 promotes hepatocellular carcinoma through reducing the RPL11-MDM2-p53 signaling
por: Cao, Pengbo, et al.
Publicado: (2021) -
RPL34‐AS1–induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2‐P53 pathway
por: Zhu, Yuanhang, et al.
Publicado: (2021)